Intravenous immunoglobulin in neurological disease: a specialist review.

Intravenous immunoglobulin in neurological disease: a specialist review.

Treatment of neurological disorders with intravenous immunoglobulin (IVIg) is an increasing feature of our practice for an expanding range of indications. For some there is evidence of benefit from randomised controlled trials, whereas for others evidence is anecdotal. The relative rarity of some of...

Full description

Bibliographic Details
Main Authors:	Wiles, C, Brown, P, Chapel, H, Guerrini, R, Hughes, R, Martin, T, McCrone, P, Newsom-Davis, J, Palace, J, Rees, J, Rose, MR, Scolding, N, Webster, A
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Intravenous immunoglobulin therapy.
by: Chapel, H
Published: (1996)

Home intravenous immunoglobulin therapy.
by: Chapel, H, et al.
Published: (1988)

Hepatitis G virus in intravenous immunoglobulin - Reply
by: Healey, C, et al.
Published: (1996)

Hepatitis C and intravenous immunoglobulin - Concluding remarks
by: Chapel, H
Published: (1996)

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
by: Bain, P, et al.
Published: (1996)

Intravenous immunoglobulin and hepatitis C virus: the British episode.
by: Healey, C, et al.
Published: (1996)

OUTBREAK OF ACUTE HEPATITIS-C FOLLOWING INTRAVENOUS IMMUNOGLOBULIN THERAPY
by: Healey, C, et al.
Published: (1994)

Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.
by: Litzman, J, et al.
Published: (1996)

Guidelines: Prescribing intravenous immunoglobulin: Summary of Department of Health guidelines
by: Provan, D, et al.
Published: (2008)

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
by: Bjorkander, J, et al.
Published: (2000)

Placebo-controlled trial of intravenous immunoglobulin in ANCA-associated systemic vasculitis.
by: Jayne, D, et al.
Published: (1999)

Intravenous immunoglobulin for the treatment of childhood encephalitis
by: Iro, M, et al.
Published: (2017)

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.
by: Jayne, DR, et al.
Published: (2000)

Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review.
by: Dicato, M, et al.
Published: (1991)

Canomad presenting without ophthalmoplegia and responding to intravenous immunoglobulin.
by: Kam, C, et al.
Published: (2011)

Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
by: Healey, C, et al.
Published: (1996)

Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin.
by: Brennan, V, et al.
Published: (2003)

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia.
by: Gamm, H, et al.
Published: (1988)

Is it safe to switch from intravenous immunoglobulin to subcutaneous immunoglobulin in patients with common variable immunodeficiency and autoimmune thrombocytopenia?
by: Scheuerlein, P, et al.
Published: (2018)

Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience
by: Kinsella, JA, et al.
Published: (2018)

Intravenous immunoglobulin-induced haemolysis: A case report and review of the literature
by: Desborough, M, et al.
Published: (2014)

Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature.
by: Desborough, M, et al.
Published: (2014)

3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.
by: Palace, J, et al.
Published: (1991)

Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study
by: Verboon, C, et al.
Published: (2021)

Effect of treatment with intravenous immunoglobulin on quality of life in patients with stiff-person syndrome.
by: Gerschlager, W, et al.
Published: (2002)

Immunoglobulin replacement therapy for primary immunodeficiencies.
by: Peter, J, et al.
Published: (2014)

Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis.
by: McCrone, P, et al.
Published: (2012)

Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy
by: Dubey, D, et al.
Published: (2019)

Pancreas allograft thrombosis following intravenous immunoglobulin administration to treat parvovirus B19 infection.
by: Muthusamy, A, et al.
Published: (2009)

Prevalence and geographical distribution of UK congenital myasthenic syndrome patients referred to the oxford national specialist commissioning advisory group service
by: Lashley, D, et al.
Published: (2007)

Self-infusion with immunoglobulin at home.
by: Chapel, H, et al.
Published: (1991)

Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy
by: Dubey, D, et al.
Published: (2019)

Immunomodulatory properties of IgG glycosylation and the anti-inflammatory mechanism of intravenous immunoglobulin
by: Yu, X
Published: (2013)

MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS).
by: Fazekas, F, et al.
Published: (2005)

Childhood encephalitis in the United Kingdom - epidemiology, trends in hospital admissions and the role of intravenous immunoglobulin
by: Iro, M
Published: (2018)

Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy.
by: Crispin, M, et al.
Published: (2013)

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
by: Hill, M, et al.
Published: (2023)

A HaemSTAR-led, UK-wide ‘flash-mob’ audit of intravenous immunoglobulin use in immune thrombocytopenia
by: Nicolson, P, et al.
Published: (2019)

Subcutaneous immunoglobulin replacement therapy: the European experience.
by: Chapel, H, et al.
Published: (2013)

A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan.
by: Walwyn, R, et al.
Published: (2013)